No Data
No Data
Needham Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $30
Privia Health Price Target Maintained With a $30.00/Share by Needham
Needham Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Olema Pharmaceuticals (OLMA) and Privia Health Group (PRVA)
Have Privia Health Group Insiders Been Selling Stock?
Buy Rating for Privia Health Group: Stability and Growth Amid Medicare Model Changes